Understand estrogen, instead of measuring it

Estrogen and the brain

The female brain uses around 20 percent more glucose than the male brain on average, and estrogen steers that energy metabolism. In 2017, Mosconi and colleagues used FDG-PET imaging in 43 clinically healthy women aged 40 to 60 and showed that cerebral glucose use already falls in perimenopause - in exactly the brain regions that later become Alzheimer-vulnerable (Mosconi et al., 2017 [1]). Mitochondrial activity in the brain cells fell in parallel. That explains part of the brain fog many women describe from their mid-forties, and it is one biological trail for why women carry two thirds of the Alzheimer's burden.

Estrogen, LDL and the heart

As long as estrogen is circulating, it keeps the LDL receptors in the liver active and cholesterol clearance steady. When the level falls, the blood picture changes in a measurable way. In 2019, Ambikairajah and team showed in a meta-analysis of 114,655 women from 66 studies that postmenopausal women, compared with premenopausal women, have on average higher triglycerides, higher total cholesterol and, above all, LDL cholesterol 0.45 mmol/L higher (Ambikairajah et al., 2019 [2]). HDL stays the same. In other words: the risk ratio shifts systematically in an unfavourable direction, and not because lifestyle suddenly failed, but because a hormone was lost. An LDL jump at 45 without a new diet mistake is therefore not a reason for self-blame. It is a signal that metabolism has flipped a switch. Anyone who wants to take this further looks at ApoB, the particle-number marker that maps the LDL reality more precisely than the standard LDL value.

Estrogen, insulin and belly fat

Estrogen keeps adipocytes where they are less dangerous: on the hips and thighs. When the level falls, fat moves into the abdomen and around the organs. That visceral fat is hormonally active, releases inflammatory messengers and pushes insulin resistance. That is why many women from 45 report that the old diet strategies no longer work. The calorie balance is not the main problem; the fat-distribution key is. {{callout}} That is what makes fasting insulin an interesting early indicator: it often shows change years before HbA1c or fasting glucose stand out.

Estrogen and bone

This is where the largest misunderstanding sits. Yes, estrogen slows bone resorption. But bone is not a hormone-only story; it is a mechanical and nutritional system. The bone matrix is around 30 percent collagen protein. With too little protein it becomes brittle, regardless of the estrogen level. Groenendijk and team showed in a 2019 meta-analysis of twelve cohort studies that protein intake above the recommended 0.8 g per kilogram lowers hip-fracture risk in older adults by 11 percent (hazard ratio 0.89) (Groenendijk et al., 2019 [3]). Watson and team showed in the 2018 LIFTMOR trial with 101 postmenopausal women with low bone density that eight months of high-intensity resistance training raised lumbar-spine bone density by 2.9 percent, while the comparison group lost 1.2 percent (Watson et al., 2018 [4]). Calcium plus vitamin D additionally lowers fracture risk by 15 percent, and hip-fracture risk by 30 percent (Weaver et al., 2016 [5]). Eating 40 prunes a day helps measurably too (De Souza et al., 2022 [6]). That is a supplementary lever, not the main strategy. The point worth keeping: four lifestyle levers (vitamin D, protein, strength training, creatine) act on bone through mechanics and nutrition. They do not replace medical care, and they do not require a single estradiol reading to start.

Estrogen, thyroid and sleep

Estrogen talks to the thyroid system on several levels. It raises the transport protein TBG, which binds fT4, and it influences the conversion of T4 to T3. In perimenopause, many women tip into a subclinical Hashimoto pattern that the standard TSH value misses. We unpacked that in Thyroid: why TSH alone misses 5 of 7 patterns. Anyone in perimenopause with new fatigue, weight change and feeling cold should want to see fT3, fT4 and Anti-TPO, not TSH alone. Sleep adds a second effect: estrogen stabilises deep-sleep architecture. When the level falls, sleep fragments, the cortisol axis compensates, and in the morning recovery no longer feels like recovery.

Why aescolab does not measure estradiol

Here is the honest answer to the obvious question: why would a blood-analysis company skip the very hormone this article is about? Three measurement reasons. First: estradiol swings hourly in perimenopause. A value at ten in the morning and one at three in the afternoon can differ by a factor of three, with nothing pathological behind it. Second: the value is only meaningful in its cycle phase, and that phase is often no longer clearly defined in perimenopause. Third: a single reading leads to false conclusions more often than to clarity - both in the direction of “everything is in range, so everything is fine” and in the direction of “value is low, so hormone deficiency”. The consequence: aescolab concentrates on the markers that still allow action in the hormonal transition. A blood test is not a diagnosis.

What aescolab tests instead

Four markers give more room to act in perimenopause than a single estradiol reading, plus a fifth on the way:

• Thyroid: TSH plus fT3 plus Anti-TPO
• Ferritin
• Vitamin D
• Omega-3 index

Those four, with the fifth still landing, cover the systems this article walked through - brain energy, lipids, visceral fat and insulin, bone, thyroid and sleep - without a swinging single value pretending to simplify the picture.

{{zitat}}

{{cta}}